Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
about
Chinese guidelines on the management of renal cell carcinoma (2015 edition)Sequence of treatment in locally advanced and metastatic renal cell carcinomaHeme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib.The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.What's new in the treatment of metastatic kidney cancer?Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.Side effects of cytokines approved for therapy.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
P2860
Q26772206-72E74BE0-D1EA-4A47-A30E-443E3E4F8AE4Q26773653-DA379B6B-2F2B-4C6C-9AFB-AF371D64AD0EQ27853203-DCB23B11-5FB8-4DD2-8E84-F70862252D76Q35827701-87DF1063-4540-4503-A7AF-55635845EE3CQ36126876-48C9CE17-DF6D-460F-9E80-F1AFBBC5C051Q38059516-A1176D20-08AA-4642-BD7E-43EF0C5CB877Q38255698-47A764EE-CADF-484F-8D4A-5031574E2A7AQ56892924-F1E2567B-FF1D-4EB5-BDC5-2B44F76F6D81
P2860
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@ast
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@en
type
label
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@ast
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@en
prefLabel
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@ast
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@en
P2093
P2860
P356
P1476
Safety and efficacy of subcuta ...... etastatic renal cell carcinoma
@en
P2093
H von der Maase
J M Tourani
P F Geertsen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601709
P407
P577
2004-03-01T00:00:00Z